Acrolein induced DNA damage, mutagenicity and effect on DNA repair

Molecular Nutrition and Food Research

Volumn 55, Issue 9, 2011, Pages 1291-1300

  Tang, Moon Shong ^a   Wang, Hsiang Tsui ^a   Hu, Yu ^a   Chen, Wei Sheng ^a,b   Akao, Makoto ^a,c   Feng, Zhaohui ^a,d   Hu, Wenwei ^a,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NIHON UNIVERSITY   (Japan)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Acrolein; DNA damage; Lung cancer; Mutation; Repair

Indexed keywords

ACROLEIN; CARCINOGEN; PROTEIN P53;

ANIMAL; BLADDER TUMOR; CARCINOGEN TESTING; CHEMISTRY; DNA ADDUCT; DNA DAMAGE; DNA REPAIR; GENETICS; HUMAN; LIPID PEROXIDATION; LUNG TUMOR; METABOLISM; MUTAGEN TESTING; MUTATION; RAT; REVIEW;

ACROLEIN; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; DNA REPAIR; HUMANS; LIPID PEROXIDATION; LUNG NEOPLASMS; MUTAGENICITY TESTS; MUTATION; RATS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

RATTUS;

EID: 80052605887     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100148     Document Type: Review

References (41)

1. Stevens, J. F., Maier, C. S., Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 2008, 52, 7-25.
2. Chung, F. L., Chen, H. J., Nath, R. G., Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts. Carcinogenesis 1996, 17, 2105-2111.
3. Comes R, M. M., Eggleton M, Concise International Chemical Assessment Document, No. 43 (World health Organization), 2002.
4. Esterbauer, H., Schaur, R. J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11, 81-128.
5. Minko, I. G., Kozekov, I. D., Harris, T. M., Rizzo, C. J., et al., Chemistry and biology of DNA containing 1, N(2)-deoxyguanosine adducts of the alpha, beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 2009, 22, 759-778.
6. Chung, F. L., Young, R., Hecht, S. S., Formation of cyclic 1, N2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res. 1984, 44, 990-995.
7. Fujioka, K., Shibamoto, T., Determination of toxic carbonyl compounds in cigarette smoke. Environ. Toxicol. 2006, 21, 47-54.
8. Luo, J., Hill, B. G., Gu, Y., Cai, J., et al., Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H3673-H3684.
9. Feng, Z., Hu, W., Hu, Y., Tang, M. S., Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. USA 2006, 103, 15404-15409.
10. Zhang, S., Villalta, P. W., Wang, M., Hecht, S. S., Detection and quantitation of acrolein-derived 1, N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem. Res. Toxicol. 2007, 20, 565-571.
11. Wang, H. T., Zhang, S., Hu, Y., Tang, M. S., Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem. Res. Toxicol. 2009, 22, 511-517.
12. Cai, Y., Wu, M. H., Ludeman, S. M., Grdina, D. J., Dolan, M. E., Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res. 1999, 59, 3059-3063.
13. Cai, Y., Wu, M. H., Xu-Welliver, M., Pegg, A. E., Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases. Cancer Res. 2000, 60, 5464-5469.
14. Hansen, R. J., Ludeman, S. M., Paikoff, S. J., Pegg, A. E., Dolan, M. E., Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals. DNA Repair 2007, 6, 1145-1154.
15. Tanel, A., Averill-Bates, D. A., Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J. Pharmacol. Exp. Ther. 2007, 321, 73-83.
16. Irwin, R. D., NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Toxic Rep. Ser. 2006, 1-73, A71-H10.
17. Jia, L., Zhang, Z., Zhai, L., Bai, Y., Protective effect of lipoic acid against acrolein-induced cytotoxicity in IMR-90 human fibroblasts. J. Nutr. Sci. Vitaminol. 2009, 55, 126-130.
18. Curren, R. D., Yang, L. L., Conklin, P. M., Grafstrom, R. C., Harris, C. C., Mutagenesis of xeroderma pigmentosum fibroblasts by acrolein. Mutat. Res. 1988, 209, 17-22.
19. Kim, S. I., Pfeifer, G. P., Besaratinia, A., Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 2007, 67, 11640-11647.
20. Roy, J., Pallepati, P., Bettaieb, A., Averill-Bates, D. A., Acrolein induces apoptosis through the death receptor pathway in A549 lung cells: role of p53. Can. J. Physiol. Pharmacol. 2010, 88, 353-368.
21. Kern, J. C., Kehrer, J. P., Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem. Biol. Interact. 2002, 139, 79-95.
22. Luo, J., Robinson, J. P., Shi, R., Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem. Int. 2005, 47, 449-457.
23. Tanel, A., Averill-Bates, D. A., The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim. Biophys. Acta 2005, 1743, 255-267.
24. Sun, L., Luo, C., Long, J., Wei, D., Liu, J., Acrolein is a mitochondrial toxin: effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Mitochondrion 2006, 6, 136-142.
25. Li, X., Liu, Z., Luo, C., Jia, H., et al., Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic. Biol. Med. 2008, 44, 1465-1474.
26. Roy, J., Pallepati, P., Bettaieb, A., Tanel, A., Averill-Bates, D. A., Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells. Chem. Biol. Interact. 2009, 181, 154-167.
27. Huang, X. S., The Roles of Mitochondria and Reactive Intermediate Species in Asbestos-Induced Mutagenesis, Ph.D. thesis, Columbia University, 2009.
28. Yang, I. Y., Chan, G., Miller, H., Huang, Y., et al., Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells. Biochemistry 2002, 41, 13826-13832.
29. VanderVeen, L. A., Hashim, M. F., Nechev, L. V., Harris, T. M., et al., Evaluation of the mutagenic potential of the principal DNA adduct of acrolein. J. Biol. Chem. 2001, 276, 9066-9070.
30. Yang, I. Y., Hossain, M., Miller, H., Khullar, S., et al., Responses to the major acrolein-derived deoxyguanosine adduct in Escherichia coli. J. Biol. Chem. 2001, 276, 9071-9076.
31. Kawanishi, M., Matsuda, T., Nakayama, A., Takebe, H., et al., Molecular analysis of mutations induced by acrolein in human fibroblast cells using supF shuttle vector plasmids. Mutat. Res. 1998, 417, 65-73.
32. Kanuri, M., Minko, I. G., Nechev, L. V., Harris, T. M., et al., Error prone translesion synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. J. Biol. Chem. 2002, 277, 18257-18265.
33. Sanchez, A. M., Minko, I. G., Kurtz, A. J., Kanuri, M., et al., Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived alpha-HOPdG and gamma-HOPdG regioisomeric deoxyguanosine adducts. Chem. Res. Toxicol. 2003, 16, 1019-1028.
34. Minko, I. G., Washington, M. T., Kanuri, M., Prakash, L., et al., Translesion synthesis past acrolein-derived DNA adduct, gamma-hydroxypropanodeoxyguanosine, by yeast and human DNA polymerase eta. J. Biol. Chem. 2003, 278, 784-790.
35. Stone, M. P., Cho, Y. J., Huang, H., Kim, H. Y., et al., Interstrand DNA cross-links induced by alpha, beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc. Chem. Res. 2008, 41, 793-804.
36. Minko, I. G., Kozekov, I. D., Kozekova, A., Harris, T. M., et al., Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adducts. Mutat. Res. 2008, 637, 161-172.
37. Huang, H., Kozekov, I. D., Kozekova, A., Rizzo, C. J., et al., Minor groove orientation of the KWKK peptide tethered via the N-terminal amine to the acrolein-derived 1, N2-gamma-hydroxypropanodeoxyguanosine lesion with a trimethylene linkage. Biochemistry 2010, 49, 6155-6164.
38. Alexandrov, K., Cascorbi, I., Rojas, M., Bouvier, G., et al., CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers' lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis 2002, 23, 1969-1977.
39. Gyorffy, E., Anna, L., Gyori, Z., Segesdi, J., et al., DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Carcinogenesis 2004, 25, 1201-1209.
40. Ghilarducci, D. P., Tjeerdema, R. S., Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 1995, 144, 95-146.
41. Kehrer, J. P., Biswal, S. S., The molecular effects of acrolein. Toxicol. Sci. 2000, 57, 6-15.